business.financialpost.com
CORRECTED-UPDATE 1-U.S. FDA approves Karyopharm Therapeutics’ blood cancer drug
The U.S. Food and Drug Administration on Wednesday approved Karyopharm Therapeutics Inc’s treatment for multiple myeloma, a type of blood cancer.The drug Xpovio was approved in combination wi…